Publication

Albuminuria, kidney function, and sudden cardiac death: Findings from The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study

Downloadable Content

Persistent URL
Last modified
  • 05/21/2025
Type of Material
Authors
    Rajat Deo, University of PennsylvaniaYulia A. Khodneva, University of AlabamaMichael G. Shlipak, University of California, San FranciscoElsayed Z. Soliman, Wake Forest UniversitySuzanne E. Judd, University of AlabamaWilliam McClellan, Emory UniversityTodd M. Brown, University of AlabamaJ. David Rhodes, University of AlabamaOrlando M. Gutiérrez, University of AlabamaSanjiv J. Shah, Northwestern UniversityChristine M. Albert, Brigham and Women's Hospital and Harvard Medical SchoolMonika M. Safford, Weill Cornell Medical College
Language
  • English
Date
  • 2017-01-01
Publisher
  • Elsevier
Publication Version
Copyright Statement
  • © 2016 Heart Rhythm Society
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1547-5271
Volume
  • 14
Issue
  • 1
Start Page
  • 65
End Page
  • 71
Grant/Funding Information
  • This research project is supported by a cooperative agreement U01 NS041588 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service.
  • Dr. Deo was supported by grant K23DK089118 from the National Institutes of Health.
  • The REGARDS-MI study was supported by NIH grants R01 HL080477 and K24 HL111154.
Supplemental Material (URL)
Abstract
  • Background: Moderate-to-severe kidney disease increases risk for sudden cardiac death (SCD). Limited studies have evaluated how mild degrees of kidney dysfunction impact SCD risk. Objective: The purpose of this study was to evaluate the association of albuminuria, which is one of the earliest biomarkers of kidney injury, and SCD. Methods: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study is a prospective, population-based cohort of U.S. adults. Associations between albuminuria, which is categorized using urinary albumin-to-creatinine ratio (ACR), estimated glomerular filtration rate (eGFR), and SCD were assessed independently and in combination. Results: After median follow-up of 6.1 years, we identified 335 SCD events. Compared to participants with ACR < 15 mg/g, those with higher levels had an elevated adjusted risk of SCD (ACR 15–30 mg/g, hazard ratio [HR] 1.53, 95% confidence interval [CI] 1.11–2.11; ACR > 30 mg/g, HR 1.56, 95% CI 1.17–2.11). In contrast, compared to the group with eGFR > 90 mL/min/1.73 m 2 , the adjusted risk of SCD was significantly elevated only among those with eGFR < 45 mL/min/1.73 m 2 (HR 1.66, 95% CI 1.06–2.58). The subgroup with eGFR < 45 mL/min/1.73 m 2 (n = 1003) comprised 3.7% of REGARDS, whereas ACR 15–30 mg/g (n = 3089 [11.3%]) and ACR > 30 mg/g (n = 4040 [14.8%] were far more common. In the analysis that combined ACR and eGFR categories, albuminuria consistently identified individuals with eGFR ≥60 mLmin/1.73 m 2 who were at significantly increased SCD risk. Conclusion: Low levels of kidney injury as measured by ACR predict an increase in SCD risk.
Author Notes
  • Address for correspondence: Rajat Deo, MD, MTR, 3400 Spruce Street, 9 Founders Cardiology, Philadelphia, PA 19104, Tel: (215) 615-5455, Fax: (215) 662-2879, Rajat.Deo@uphs.upenn.edu
Research Categories
  • Health Sciences, Public Health
  • Biology, Biostatistics
  • Health Sciences, Epidemiology

Tools

Relations

In Collection:

Items